Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $463.00K in the quarter ending March 31, 2026, a decrease of -60.19%. This brings the company's revenue in the last twelve months to $1.34M, down -79.52% year-over-year. In the year 2025, Dianthus Therapeutics had annual revenue of $2.04M, down -67.35%.

• Revenue (ttm): $1.34M
• Revenue Growth: -79.52%
• P/S Ratio: 3,901.52
• Revenue / Employee: $14,522
• Employees: 92
• Market Cap: 5.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.04M	-4.20M	-67.35%
Dec 31, 2024	6.24M	3.41M	120.63%
Dec 31, 2023	2.83M	-3.59M	-55.96%
Dec 31, 2022	6.42M	4.94M	334.76%
Dec 31, 2021	1.48M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 9, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error